IntuBlade, a trailblazing startup in the medical devices industry, has developed a next-generation video laryngoscope with patented lens-clearing technology. This innovative device, spearheaded by a physician with battlefield experience, aims to revolutionize intubation procedures by ensuring a clear and unobstructed view during intubations. The device's patented spray technology prevents the camera lens from being compromised by bodily fluids, eliminating the need for the cumbersome process of removing, cleaning, and reinserting traditional intubation devices. This not only reduces patient trauma and oxygenation time but also signifies a significant leap forward in medical technology. The product's USB-C connectivity allows seamless integration with proprietary apps on Android and iOS, leveraging machine learning and artificial intelligence for enhanced precision during procedures. IntuBlade's efficacy has been substantiated by studies published in the American Journal of Emergency Medicine, garnering a remarkable net promoter score of 95. With over $2 million in funding and FDA clearance as a Class 1 510(k) exempt device, IntuBlade is poised for a market launch in Q3 2024. The startup's most recent $300.00K Pre Seed Round investment, secured on 13 December 2022, came from Inflect Health. With its commitment to improving patient outcomes through innovative medical technology, IntuBlade is on a mission to establish a new standard of care in airway management.
No recent news or press coverage available for IntuBlade.